Area of research
Physiology · Psychiatry and Mental health
Research interest
Research interests include Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Neuroinflammation and Neurodegeneration Mechanisms, and Functional Brain Connectivity Studies.
Phospho-tau serine-262 and serine-356 as biomarkers of pre-tangle soluble tau assemblies in Alzheimer’s disease
The impact of kidney function on Alzheimer’s disease blood biomarkers: implications for predicting amyloid-β positivity
Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer’s disease
Amyloid beta and tau are associated with the dual effect of neuroinflammation on neurodegeneration
Exploring inflammation‐related protein expression and its relationship with TSPO PET in Alzheimer's disease
Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology
Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability
Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240
Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer’s disease pathology
Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease
A two-step workflow based on plasma p-tau217 to screen for amyloid β positivity with further confirmatory testing only in uncertain cases
Equivalence of plasma p‐tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease
Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies
<i>APOE</i> ε4 associates with microglial activation independently of Aβ plaques and tau tangles
Neuropsychiatric Symptoms and Microglial Activation in Patients with Alzheimer Disease
Plasma p‐tau231 and p‐tau217 inform on tau tangles aggregation in cognitively impaired individuals
Sex-specific modulation of amyloid-β on tau phosphorylation underlies faster tangle accumulation in females
APOEε4 potentiates amyloid β effects on longitudinal tau pathology
Potential Utility of Plasma P-Tau and Neurofilament Light Chain as Surrogate Biomarkers for Preventive Clinical Trials
Biomarker modeling of Alzheimer’s disease using PET-based Braak staging
Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography
Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease
Comparing tau status determined via plasma pTau181, pTau231 and [18F]MK6240 tau-PET
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
Microglial activation and tau propagate jointly across Braak stages
Association of plasma P-tau181 with memory decline in non-demented adults
Mild behavioral impairment is associated with β‐amyloid but not tau or neurodegeneration in cognitively intact elderly individuals
Application of Neonatologist Performed Echocardiography in the Assessment and Management of Neonatal Heart Failure unrelated to Congenital Heart Disease
Recommendations for neonatologist performed echocardiography in Europe: Consensus Statement endorsed by European Society for Paediatric Research (ESPR) and European Society for Neonatology (ESN)